Nasal Vaccine

Glenmark's Ryaltris nasal spray gets China approval for allergic rhinitis

Glenmark Pharmaceuticals Ltd on Monday said its arm Glenmark Specialty SA has received approval from China's National Medical Products Administration for the nasal spray RYALTRIS used to treat allergic rhinitis. The National Medical Products Administration (NMPA) of China has approved RYALTRIS Compound Nasal Spray (GSP 301 NS) for the treatment of allergic rhinitis (AR) in adults and children -- specifically for treatment of moderate to severe seasonal AR in adults and pediatric patients 6 years of age and older, and moderate to severe perennial AR in adults and pediatric patients 12 years of age and older, the company said in a statement. The approval granted with zero supplementation requests is an important milestone in Glenmark's respiratory pipeline and reflects continued progress in advancing innovative and differentiated therapies for patients with chronic conditions, it added. "The approval of RYALTRIS in China is a significant step in expanding our specialty respiratory ...

US govt to fund up to $500 mn for studies on oral, nasal Covid vaccines

The funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced Research and Development Authority (BARDA)

All you need to know about world's first nasal vaccine for covid

The government has approved Bharat Biotech's intranasal Covid-19 vaccine, iNCOVACC (BBV154), as a booster dose for those above 18 years of age. How does this needle-free vaccine work and how different is it from the existing ones? To get the answers, Business Standard spoke to Dr Gagandeep Kang, virologist and professor at the Christian Medical College, Vellore. Watch the video for more

India's nasal vaccine not for those who have taken booster: NTAGI chairman

The Indian nasal vaccine cannot be given to those who have allready taken a precaution or booster dose, the head of the country's vaccine task force said

Covid-19: Bharat Biotech's nasal vaccine gets govt nod as booster shot

The approval for the vaccine comes amid a spurt in Covid cases in China and some other countries

Bharat Bio looks for partners to manufacture, distribute iNCOVACC globally

Its local production ramp-up remains unhurried as demand for boosters reduces

Bharat Biotech gets nasal vaccine nod for use as mix-match booster

iNCOVACC first intranasal Covid shot to receive approval for primary 2-dose schedule, heterologous booster us

Nasal vaccines for Covid-19: How do they work and what are their benefits?

The Drugs Controller General of India (DCGI), on Tuesday, approved Bharat Biotech's anti-covid vaccine for emergency use. It is the first such vaccine in the country

TMS Ep255: Car safety, retirement age, auto ancillary cos, nasal vaccine

How can India make its cars safer? Should India consider raising the retirement age? Are auto ancillaries a favourable bet as commodity costs ease? How do nasal vaccines work? Answers here

What are nasal vaccines and how do they work?

The Drugs Controller General of India has approved the first intra-nasal Covid-19 vaccine for restricted use. A few drops in both the nostril will keep the virus at bay. Let us find out more

Fight against Covid-19: Here is a list of vaccines approved in India

Besides Bharat Biotech's nasal vaccine, India has 13 vaccines to fight against Covid-19. Two have been approved for manufacturing, while 11 have been approved for emergency use

Glenmark nasal spray cuts down viral load of Covid by 94% in 24 hrs

Glenmark had conducted the study on 306 vaccinated and unvaccinated adults with symptomatic mild Covid-19 disease across 20 clinical trial sites in India

Nasal spray lowers Covid viral load by 94% in 24 hours, reveals Lancet

A nasal spray administered in high-risk adult COVID-19 patients in India reduced viral load by 94 per cent within 24 hours and 99 per cent in 48 hours

Glenmark Pharmaceuticals sees potential of NONS to prevent Covid-19

The firm, which has tasted success with its oral antiviral drug favipiravir, is now betting on the NONS to drive revenues from its Covid-19 portfolio

Booster dose: Bharat Biotech's nasal vaccine may be used with Covaxin

The idea is to see which combination induces better and long-lasting immune response

Expert panel recommends phase 1 trial of Bharat Biotech's nasal vaccine

A top government official said that if this vaccine works it can be a game changer in the fight against COVID-19

Nasal vaccine prevents coronavirus infection in mice, says new study

Scientists have developed a vaccine against Covid-19 that can be given in one dose via the nose, and is effective in preventing infection in mice susceptible to the novel coronavirus

Effectiveness of nasal vaccine questioned

The nasal spray has not been recommended for those who are immune compromised, pregnant women or nursing mothers